chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a health professional concerning a 5 year old male patient with no known drug allergies and no medical history, who was vaccinated on 07/13/1997 with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second genration)(Lot # 624669/1582E).  Subsequently, the patient developed "slight difficulty with fine motor and skilled motor skills".  He was seen by a pediatric neurologist in August 2002, and no clear cut autistic symptoms were noted.  Conflicting follow-up information received from the mother indicated the patient received measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) in 1998.  The mother expressed concern about the lot number.  the records of testing prior to release of this lot have been checked by GMP Compliance and found to be satisfactory.  The lot complies with the standards of the Center for Biologics Evaluation and Research and was released.  Additional information has been requested.
It burned incredibly bad going in and burned for a couple of days afterwards. It was different than the soreness from the shot. I?m reporting it bc no one else I know who got it, said anything about burning.
brain fog; headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (brain fog) and HEADACHE (headache) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (brain fog) and HEADACHE (headache). At the time of the report, FEELING ABNORMAL (brain fog) outcome was unknown and HEADACHE (headache) had resolved.            Treatment details included took asprin.   This case was linked to MOD-2021-057756 (Patient Link).
This spontaneous report was received from a nurse concerning a patient of unknown age and gender. No concurrent conditions or medical history were reported. On 31-AUG-2016, the patient was inadvertently vaccinated with an expired dose of M-M-R II with lot # M001200 Expiration date: 28-AUG-2016 (dose and anatomical location of administration were not reported). No concomitant therapy was provided. No adverse effects were reported. No Product Quality Complaint (PQC) was involved. This is one of two reports received from the same source. Additional information has been requested.
severe pain, stiffness in joints and muscles making it difficult to walk; chills leading to shaking, later fever; headache; exacerbated atrial fib and heart racing; general virus-like symptoms making it impossible to sleep or get comforable.
6hr post vax pt c/o pain, aching, throbbing pain to elbow;tingling in fingers;no temp, no redness-described as worse than worse case of tendinitis;(pt states pain lasted 24hr); using ice pack-told to take APAP;
06/13/02 erythema and induration approx 6cm radius around single site of injection.
Injured shoulder; She has chronic fatigue syndrome (CFS) for many years and has had bad flare ups; Tendinitis in her shoulder/which "hurts quite a bit"; Tendinitis in her shoulder; Wort headaches that "she ever had".; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received first dose of BNT162B2 (Formulation for injection; Batch/Lot number: unknown) via an unspecified route of administration on 07May2021 as single dose for COVID-19 immunisation. Medical history included chronic fatigue syndrome from an unknown date and unknown if ongoing for many years. The patient's concomitant medications were not reported. On an unspecified date of May2021 patient explained chronic fatigue syndrome (CFS) for many years and has had bad flare ups. She added she also has tendinitis in her shoulder, which hurts quite a bit. She mentioned 2.5-3 weeks post vaccination she had her CSF flare up and the worst headaches that she ever had. She added she will be consulting her neurologist on the 17th (failed to confirm the month), which will approach the 42 days mark post vaccination. She explained she would like to wait for this consultation before getting the second dose. She asked if the second dose can be administered beyond the 42 days. Upon follow up, she also reported that, her shoulder was injured and at the very least has tendonitis. She was 32 days out from receiving the first injection, but she wanted to know if it's okay to get the second shot to complete the vaccination series. The outcome of the events was unknown.  Follow-up (08Jun2021): This is a follow-up spontaneous report from a Pfizer sponsored program Support via consumer (patient) which included new information such as: She is 32 days out from receiving the first injection, but she wants to know if it's okay to get the second shot to complete the vaccination series/ she has had chronic fatigue syndrome for years, but she had a bad fare up. Her shoulder is also injured and at the very least has tendonitis"  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Arm was painful at injection site. Arm has continued to be painful over period of time since vaccine administered. Patient finds it difficult to raise arm above shoulder.
10/22/16 Parents report foot and leg swelling. 10/24/16 Puffiness (Lt) thigh no redness. 10/26/16 Few red spots on lower legs bilateral. 10/27/16 Swelling of (Lt) hand dorsal -> can use fingers and hand as usual.
Rash (itchy, burning, splotchy, light red to chest at night) for the past 4 nights.  Only occurring at night, also developed redness like "rosacea" to her face and last night itching to the palms of her hands.  Took Benadryl last night with resolution of the symptoms. Has had itching to B legs, noticed "burning pain" to legs, putting a pillow between her legs seemed to help. First night of rash was the worst. Denies wheezing, SOB, throat tightening, problems swallowing, drooling, lip swelling.
Approx. 5 min after receiving shot I had extreme dizziness and felt flushed. Approx. 12:10 PM I took liquid Benadryl while at pharmacy and a Singulair when I got home.
The day after receiving vaccine pt. started feeling fatigued and sinusitis. Pt. sent home on supportive care and on abx for concurrent otitis media.
FACE BEGAN TO TINGLE THEN TONGUE BEGAN TO SWELL. I WAS FINDING IT TO BE AN EFFORT TO TAKE IN A BREATHE. OVER THE NEXT 48 HOURS MY OTHER AREAS WHERE I HAD BEEN BITTEN BY FIRE ANTS AND A HORNET STING BEGAN TO SWELL AGAIN AND MORE BENADRYL AND PEPCID
My mother has had her share of health problems predominantly relating to her Afib diagnosis,however after every dose she experienced side effects that have set her back in ways that were completely new,loss of memory Sluring her words, really bad head aches leading up to the first and second stroke.She was able to drive live on her own had sweet and kind,funny personality now that is all gone. She is a shell of who she was and our family just simply misses her,I truly just wish that we would have had been warned of the possible risks to patients like her prior to getting the vaccine.No matter how small the possibility of adverse reaction.We would have chosen to keep her longer.
Glucose always within normal limits. Labs drawn 1week after 1st vaccine reported glucose 444. Glucose 250 to 350 the next week and then over 200 to 250 the next 3 weeks.
Approximately 24 hours post vax, pt developed a lump at injection site .5 inch in diameter, then redness and tenderness. The redness and tenderness resolved after 3 days. A soft lump .25 inch in diameter remains. The most recent information reports the outcome of the event is ongoing.
A 2 year long explosive diarrhea episode with diarrhea after eating; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient received BNT162b2 (BNT162B2), on 01Nov2021 as dose 3 (booster), single (Lot number: FF2593) at the age of 65 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroid" (unspecified if ongoing), notes: Hypothyroid; "Food skin test: Stringbeans/Greenbeans" (unspecified if ongoing), notes: Food skin test: Stringbeans/Greenbeans, RXN: +/- (Questionable response); "Food skin test: Histamine" (unspecified if ongoing), notes: Food skin test: Histamine, RXN: 2 (moderate allergic) - 3 (Highly allergic). Concomitant medication(s) included: NP THYROID oral taken for hypothyroidism (ongoing). Vaccination history included: BNT162b2 (DOSE 1, SINGLE , Anatomical site of injection: Right Arm, Batch/Lot number: EP7534, EXP:30Jul2021), administration date: 20Mar2021, when the patient was 64-year-old, for COVID-19 Immunization; BNT162b2 (DOSE 2, SINGLE , Anatomical site of injection: Right Arm, Batch/Lot number: EW0162, EXP:31Jul2021), administration date: 10Apr2021, when the patient was 64-year-old, for COVID-19 Immunization, reaction(s): "Diarrhea", "Granuloma annulare".  The following information was reported: DIARRHOEA (medically significant), outcome "unknown", described as "A 2 year long explosive diarrhea episode with diarrhea after eating". The patient underwent the following laboratory tests and procedures: Biopsy skin: (unspecified date) Unknown results; Blood gastrin (0-115): (03Feb2022) 27 pg/mL; Blood test: (unspecified date) nothing showed up; Computerised tomogram intestine: (unspecified date) CT enterograpgy look fine.; a volumetric pre- and post-contrast scan: (unspecified date) Unknown results; Somatostatin receptor scan: (03Feb2022) <21 pg/mL; Stool analysis: (unspecified date) nothing showed up on test; Urine analysis: (07Feb2022) 1.1 mg/l; Urine analysis (0.0-14.9): (07Feb2022) 3.0 mg/24h; Urine analysis: (unspecified date) Unknown results; Vasoactive intestinal polypeptide test (0.0-58.8): (03Feb2022) 28.0 pg/mL. Therapeutic measures were taken as a result of diarrhoea.   Clinical course: Clinical course: Within 4-5 days of receiving the second vaccine on 10Apr2021, patient began a 2 year long explosive diarrhea episode with diarrhea after eating from morning until 3 pm every day [only ate breakfast] which caused her to become homebound. Patient had stool tests, blood tests, treatment with antibiotics- nothing showed upon tests, treatment did not work. Clinical History was chronic diarrhea.  Vaccination Facility type was public health clinic. No Prior Vaccinations (within 4 weeks). No Specific Relevant test for Thromboembolic with Thrombocytopenia.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300091602 same patient/reporter, different vaccine dose;US-PFIZER INC-202300219761 same patient/reporter, different vaccine dose;
Within one day following the vaccine, I experienced 24 hours of the same symptoms I had when I contracted covid-19 in November 2020.  Since then I've had muscle and joint pain that is not normal for me.  I've also had occasional chills and a general feeling of weakness.  This has been for 3 weeks now.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition or medical history was reported. On 10-FEB-2016, the patient was vaccinated with ZOSTAVAX (lot # L028282, exp. 28-OCT-2016, dose not provided, subcutaneous). No concomitant therapy was reported. It was reported that while vaccination the last 0.1 ml did not go into the patient. The reporter stated that either the needles was leaking or there was a problem with the patent's skin. No adverse effects were reported. The outcome of the event was unknown. No product quality issue was involved. Additional information has been requested.
Pain at injection site; Aching; Chills; Rash; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th October 2020, the patient received the 1st dose of Shingrix. In October 2020, less than a week after receiving Shingrix, the patient experienced injection site pain, pain, chills and rash. On an unknown date, the outcome of the injection site pain, pain, chills and rash were unknown.   It was unknown if the reporter considered the injection site pain, pain, chills and rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter was the father of the patient and reported that his daughter received the first dose day before reporting date and had aching, chills, pain at the injection site, and a rash. The reporter did not consent to follow-up and did not wanted to provide any additional information regarding these events.
Client reports that she had soreness and tenderness for 1-2 days in her left Deltoid where the vaccine was administered and then felt a lump in the same area.  Then 10-11 days later she reported that her left Deltoid become red and itchy, and she developed a welt.  She went to Urgent Care and the Physician diagnosed her with Cellulitis. She said they measured the welt as 4 1/2"  x 6 1/2 " and treated her with topical Benadryl and oral antibiotics.  She reported that the antibiotics were helping and the redness and swelling were decreasing.
I must note that on my vaccination card it reads ID Biomedical as the manufacturer. Not sure if they are a subset of GlaxoSmithKline? On 4 Dec 2017, I received my annual flu shot from my employer. Two hours after the shot, my arm was numb with pins and needles in it. I also had shooting pains in my hands. A few hours later, the pain was going through my whole arm, up past my collar bone up to my neck. I was also having pins and needle sensations on top of my head from ear to ear. All this lasted until the next morning. The next morning I only had left some pain on top of my shoulders, and tenderness at the injection site. But it felt like the reaction was going away, or so I thought. On 10 Dec 2017, I woke up with shooting pains in my right leg hip joint/hip flexor area. It hurt to walk. On 11 Dec 2017, the pain increased. It went just below my hip joint/hip flexor area to the top of my hip bone. Again it hurt to walk and I was noticeably limping. Fast forward to 14 Dec 2017, and the pain has decreased, but the pain has spread down to my knee. I am also getting tingling in my toes. I am still having to limp from the pain and tingling in my right hip/leg. When I press on my leg it feels tender and feels like I have been bruised. As of 10 Jan 2018, I am still having pain, and pins and needles feeling in my right hip/leg. Pain, pins and needles, and the ability to walk without pain finally healed end of Feb 2018.
received my Moderna vaccine and I am pregnant; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (received my Moderna vaccine and I am pregnant) in a 38-year-old female patient (gravida 4, para 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     Concurrent medical conditions included Pregnant and Thyroid disorder NOS.    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 25-Feb-2021. On 10-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (received my Moderna vaccine and I am pregnant). On 10-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (received my Moderna vaccine and I am pregnant) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This is a case of product exposure during pregnancy with no associated AEs for this 38-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 38-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy
PATIENT PLACED ON VENTILATOR; DEATH; COVID PNEUMONIA; This spontaneous report received from a consumer via a company representative via social media concerned a 49 year old female of unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient had no health problems. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry unknown) dose was not reported, administered in late APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. In late APR-2021, on the night of vaccination, the patient experienced flu like symptoms. She was hospitalized and was in intensive care unit (ICU) (date unspecified), she never got better from flu like symptoms. It was claimed that the patient had Covid pneumonia. On an unspecified date, patient experienced sever lung damage and lung complications, and the patient was placed on ventilator.  On 02-MAY-2021, the patient died from unknown cause of death It was unknown if the autopsy was performed. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient died of death on 02-MAY-2021, and the outcome of covid pneumonia and patient placed on ventilator was not reported. This report was serious (Death, Hospitalization Caused / Prolonged, and Life Threatening).; Sender's Comments: V0 -20210731688-Covid-19 vaccine ad26.cov2.s-Death, Covid Pneumonia, Patient placed on ventilator. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
woke up in middle of night; injection site hurt; injection site hard; injection site swelling; A spontaneous report was received from a Consumer concerning a 79-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events woke up in the middle of the night, hurting injection site, hard injection site, swollen injection site.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 2 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 038K20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 13 Feb 2021, the patient experienced the events woke up in the middle of the night. hurting injection site, hard injection site, swollen injection site.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events were not applicable  On an unknown date the outcome of events, woke up in the middle of the night, On an unknown date the outcome of events, hurting injection site, On an unknown date the outcome of events, hard injection site, On an unknown date the outcome of events, swollen injection site was not reported.
Patient developed lightheadedness within several minute of vaccine. vitals done 126/70 o2 96% hr 88 patient   still was lightheaded brought to stretcher and was seen by ER Dr - patient was feeling better felt ok to d/c   home. felt 100% walked to lobby
Kidney pain started late Dec 11th and has continued, dark colored urine, chills, sweats, high fever, fatigue, burning and watery eyes.
SX occurred 5/15/2006 right arm began hurting aching. 5/18/06 SX's right arm swollen, aching,  Pain right shoulder joint, right side neck swelling, back hurting, right tricep slight swollen, right side of chest, hot, swollen, rash light in color, confluent.
Symptoms - Severe fatigue, headaches, body aches, feeling feverish, nausea, brain fog Treatment - Acetaminophen 1,000 mg every 8 hours Outcomes - Ongoing
Patient mistakenly received 0.3 ml of the Pfizer vaccine prior to reconstitution with normal saline. The patient has not experienced any adverse effects as of 15 minutes after the vaccine.
she cannot remember much; This is a spontaneous report from a sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 03Feb2021 at SINGLE DOSE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced she cannot remember much. The patient stated, "I don't know if its the vaccine or what?" The patient also reported that she was indicated for second dose on 17Feb2021. Asking for aid in transportation to "name" and if able to confirm appointment. The outcome of the event she cannot remember much was unknown.  Information on the lot/batch number has been requested.
First shot uneventful. Second shot, patient had a fall the next morning, where his knees weakened and gave out. He had been active prior to this, without similar events. He also had extreme brain fog, and has had long-lasting fatigue, weakness and decreased appetite since then. This writer saw him 4/5/2021. He has now developed thrush without any evident cause.  He did lose his sense of taste but that is returning.
Swelling below vaccine site, redness, slight warm, pain. Further investigation patient had possibly received PNEUMOVAX 23 10/5/2010.
I have a history of breast cancer, but I had a new diagnoses of triple negative breast cancer in the same breast. I had surgery and did chemo. They got all the cancer out with surgery. I am recovering now.
Myalgia & Arthralgia Narrative:  1st day post vaccine, minimal soreness. 5th day post vaccine "developed impingement" per employee, pain raising L arm with limited ROM. Weakness with grip and arm. Employee has been resting L arm and using it minimally and taking OTC ibuprofen BID. Employee claims L arm is about 50-60% getting better but still with discomfort.
Patient complained of shortness of breath. Onsite EMS was called vitals  HR 77 BP 136/90 100% BG 226. She had taken hermedications this morning. 25 mg Diphenhydramine was given. She was transported to the E.R.
Infection Control Nurse emails NP on 27FEB12 reporting inpatient admit on 24FEB12 via ER to 4-South for suspect SPV associated myocarditis. Patient is 19 y/o who recv'd his primary SPV (LUE) on 13FEB12 and AVA#1, Hep A#2, Typhoid ViCPs (RUE) on 10FEB12.